2 01/04/2024 31/03/2025 2025-03-31 false false false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2024-04-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 07342116 2024-04-01 2025-03-31 07342116 2025-03-31 07342116 2024-03-31 07342116 2023-04-01 2024-03-31 07342116 2024-03-31 07342116 2023-03-31 07342116 bus:Director1 2024-04-01 2025-03-31 07342116 core:WithinOneYear 2025-03-31 07342116 core:WithinOneYear 2024-03-31 07342116 core:AfterOneYear 2025-03-31 07342116 core:AfterOneYear 2024-03-31 07342116 bus:Micro-entities 2024-04-01 2025-03-31 07342116 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 07342116 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 07342116 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 07342116 bus:FullAccounts 2024-04-01 2025-03-31
Company registration number: 07342116
Prologics Europe Limited
Unaudited filleted financial statements
31 March 2025
Prologics Europe Limited
Contents
Directors report
Statement of financial position and notes to the financial statements
Prologics Europe Limited
Directors report
Year ended 31 March 2025
The directors present their report and the unaudited financial statements of the company for the year ended 31 March 2025.
Directors
The directors who served the company during the year were as follows:
Mr N P Pinder
Small company provisions
This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.
This report was approved by the board of directors on 01 December 2025 and signed on behalf of the board by:
Mr N P Pinder
Director
Prologics Europe Limited
Statement of financial position
31 March 2025
2025 2024
£ £ £ £
Current assets 44,085 54,738
Prepayments and accrued income 3,250 2,875
_______ _______
47,335 57,613
Creditors: amounts falling due within one year ( 57,341) ( 61,755)
_______ _______
Net current liabilities ( 10,006) ( 4,142)
_______ _______
Total assets less current liabilities ( 10,006) ( 4,142)
Creditors: amounts falling due after more than one year ( 30,021) ( 31,200)
Accruals and deferred income ( 1,354) ( 1,350)
_______ _______
Net liabilities ( 41,381) ( 36,692)
_______ _______
Capital and reserves ( 41,381) ( 36,692)
_______ _______
Prologics Europe Limited
Year ended 31 March 2025
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsiblities:
- The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 01 December 2025 , and are signed on behalf of the board by:
Mr N P Pinder
Director
Company registration number: 07342116
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Unit 10, Firbank Court, Firbank Way, Leighton Buzzard, Beds, LU7 4YJ.